1. Home
  2. VSME vs ENLV Comparison

VSME vs ENLV Comparison

Compare VSME & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

HOLD

Current Price

$0.82

Market Cap

5.0M

Sector

N/A

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.20

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSME
ENLV
Founded
2013
2005
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.1M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
VSME
ENLV
Price
$0.82
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
612.8K
★ 1.7M
Earning Date
04-30-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.19
52 Week High
$5.38
$7.64

Technical Indicators

Market Signals
Indicator
VSME
ENLV
Relative Strength Index (RSI) 44.41 18.86
Support Level $0.75 N/A
Resistance Level $1.19 $1.26
Average True Range (ATR) 0.08 0.04
MACD -0.01 0.03
Stochastic Oscillator 53.09 2.48

Price Performance

Historical Comparison
VSME
ENLV

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: marketing services and social commerce. The firm generates almost all of its revenue from marketing services, which reflects the company's business of marketing services to clients and social media platforms. The social commerce segment reflects the company's business of social commerce with customers. Geographically, the firm generates revenue from the HK SAR and Taiwan.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: